In type 2 diabetes with CVD and kidney disease, empagliflozin reduced mortality and hospitalization
Ann Intern Med
.
2018 May 15;168(10):JC52.
doi: 10.7326/ACPJC-2018-168-10-052.
Author
Louise Moist
PMID:
29800428
DOI:
10.7326/ACPJC-2018-168-10-052
No abstract available
Publication types
Comment
MeSH terms
Benzhydryl Compounds
Cardiovascular Diseases*
Diabetes Mellitus, Type 2*
Glucosides
Hospitalization
Humans
Renal Insufficiency, Chronic*
Substances
Benzhydryl Compounds
Glucosides
empagliflozin